Understanding Osteoporosis: Bone Loss, Density & Risk
Osteoporosis is a systemic skeletal disease characterized by low bone mass, microarchitectural deterioration, and increased fragility fracture risk.
Core Pathology
- Loss of bone volume & density: Imbalance between osteoclast resorption and osteoblast formation.
- Microarchitectural decay: Trabecular thinning, loss of connectivity; cortical porosity.
Diagnosis
- DXA (T-score): ≤−2.5 at hip/spine = osteoporosis; −1.0 to −2.5 = osteopenia.
- FRAX® tool: 10-year major osteoporotic/hip fracture probability.
- Vertebral fracture assessment (VFA): Detects silent fractures.
Risk Factors
- Age >65, female sex, menopause (estrogen loss), low BMI.
- Glucocorticoids (>5 mg prednisone ≥3 mo), aromatase inhibitors, androgen deprivation.
- Smoking, alcohol (>3 units/day), sedentary lifestyle.
- Secondary causes: hyperparathyroidism, hyperthyroidism, celiac, RA, CKD.
Consequences
- Hip, vertebral, wrist fractures → pain, disability, loss of independence, increased mortality (20–24% 1-year mortality post-hip fracture).
Prevention & Treatment
- Calcium 1000–1200 mg/day (diet + supplement), Vitamin D 800–2000 IU/day.
- Weight-bearing + resistance exercise.
- Fall prevention (home safety, vision check, balance training).
- Pharmacotherapy (bisphosphonates, denosumab, anabolics) per FRAX/guidelines.
Early detection and intervention prevent fractures and preserve quality of life.
Osteoporosis - Related Articles
- Understanding Osteoporosis: Impact on the Body and Risk Factors
- Exercise for Osteoporosis: A Guide to Strengthening Bones & Managing Pain
- Osteoporosis: Symptoms, Risk Factors & Prevention
- Understanding Knee Pain: Causes, Symptoms & Treatment
- Fortical (Calcitonin): Side Effects, Risks & What to Know
- Understanding Premenopausal Osteoporosis: Causes & Risk Factors
- Actonel (Risedronate) for Osteoporosis: Uses, Dosing, Side Effects & Monitoring
